Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest Articles"Tapentadol" - A Novel Analgesic
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Tayal G et al. – Tapentadol is a new analgesic drug with a dual mode of action, hence has efficacy in a broad spectrum of acute and chronic pain models and possibly an improved tolerability profile. It combines moderate mu–opioid agonist activity with NE reuptake inhibition in a single, nonracemic molecule. No metabolic activation of tapentadol is necessary for analgesia, and it has no active metabolites. Further RCTs are needed to establish its routine use in postoperative patients.
Related Articles
Tapentadol immediate release for the relief of moderate-to-severe acute pain
Expert Opinion in Pharmacotherapy, 10/08/09
Relevance Score: 92%
Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule
Drugs of Today, 10/19/09
Relevance Score: 90%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children
Journal of Clinical Anesthesia, 12/15/09
A Comparison of Common Screening Methods for Predicting Aberrant Drug-Related Behavior among Patients Receiving Opioids for Chronic Pain Management
Pain Medicine, 12/15/09
Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor